Identification of compromised components in a medical system

In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain...

Full description

Saved in:
Bibliographic Details
Main Authors Raike, Robert S, Linde, David E, Stypulkowski, Paul H, Giftakis, Jonathon E, Denison, Timothy J, Eng, Mae, Adamski, Thomas, Stanslaski, Scott R
Format Patent
LanguageEnglish
Published 04.06.2024
Subjects
ELECTROTHERAPY
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
RADIATION THERAPY
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.
Bibliography:Application Number: US202117364609